speb/financial-data huggingface dataset:
SBIO.V balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Non Current: 28755.00
SBIO.V income_statement (annual, 2024-12-31) — EBIT: 1223075.00
SBIO.V income_statement (quarterly, 2024-12-31) — EBIT: 1532183.00
SBIO.V income_statement (annual, 2024-12-31) — EBITDA: 2105998.00
SBIO.V income_statement (quarterly, 2024-12-31) — EBITDA: 1725863.00
SBIO.V cash_flow (annual, 2024-12-31) — End Cash Position: 3300439.00
SBIO.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 3300439.00
SBIO.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: -2981841.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -662523.00
SBIO.V balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -119128.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: -119128.00
SBIO.V cash_flow (annual, 2024-12-31) — Free Cash Flow: 3670168.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 1091076.00
SBIO.V cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
SBIO.V balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -119128.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -119128.00
SBIO.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 6990057.00
SBIO.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 2415504.00
SBIO.V balance_sheet (annual, 2024-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2738996.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 2738996.00
SBIO.V balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 14805810.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 14805810.00
SBIO.V balance_sheet (annual, 2024-12-31) — Gross PPE: 3168025.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 3168025.00
SBIO.V income_statement (annual, 2024-12-31) — Gross Profit: 30627389.00
SBIO.V income_statement (quarterly, 2024-12-31) — Gross Profit: 11286755.00
SBIO.V balance_sheet (annual, 2024-12-31) — Income Tax Payable: 46575.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 46575.00
SBIO.V income_statement (annual, 2024-12-31) — Interest Expense: 1292344.00
SBIO.V income_statement (quarterly, 2024-12-31) — Interest Expense: 329055.00
SBIO.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1292344.00
SBIO.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 329055.00
SBIO.V balance_sheet (annual, 2024-12-31) — Interest Payable: 112280.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Interest Payable: 112280.00
SBIO.V balance_sheet (annual, 2024-12-31) — Invested Capital: 5883730.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 5883730.00
SBIO.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -102861.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -27343.00
SBIO.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
SBIO.V balance_sheet (annual, 2024-12-31) — Line Of Credit: 5219387.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 5219387.00
SBIO.V balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1264342.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1264342.00
SBIO.V balance_sheet (annual, 2024-12-31) — Long Term Debt: 440000.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 440000.00
SBIO.V balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1704342.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1704342.00
SBIO.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2825419.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -605877.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -13560.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -12764.00
SBIO.V balance_sheet (annual, 2024-12-31) — Net Debt: 3554938.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 3554938.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 7474.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -14358.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income: 1194528.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 1194528.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 1194528.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1194528.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1194528.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -110875.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 1194528.00
SBIO.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -110875.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 1194528.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -102861.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -27343.00
SBIO.V income_statement (annual, 2024-12-31) — Net Interest Income: -1292344.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -329055.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2825419.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -605877.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2825419.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -605877.00
SBIO.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1292344.00
SBIO.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -329055.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -148732.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -47507.00
SBIO.V balance_sheet (annual, 2024-12-31) — Net PPE: 1351893.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 1351893.00
SBIO.V cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -1908116.00
SBIO.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3710643.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -3710643.00
SBIO.V balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 28755.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 28755.00
SBIO.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
SBIO.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
SBIO.V balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 414044.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 414044.00
SBIO.V income_statement (annual, 2024-12-31) — Normalized EBITDA: 2948741.00
SBIO.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1725863.00
SBIO.V income_statement (annual, 2024-12-31) — Normalized Income: 554891.97
SBIO.V income_statement (quarterly, 2024-12-31) — Normalized Income: 1194528.00
SBIO.V balance_sheet (annual, 2024-12-31) — Notes Receivable: 0.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3773029.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 1118419.00
SBIO.V cash_flow (annual, 2024-12-31) — Operating Gains Losses: 943041.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 921209.00
SBIO.V income_statement (annual, 2024-12-31) — Operating Income: 2065818.00
SBIO.V income_statement (quarterly, 2024-12-31) — Operating Income: 2374926.00
SBIO.V income_statement (annual, 2024-12-31) — Operating Revenue: 49602885.00
SBIO.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 18301162.00
SBIO.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 50543985.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 50543985.00
SBIO.V balance_sheet (annual, 2024-12-31) — Other Current Assets: 481832.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 481832.00
SBIO.V balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1195990.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1195990.00
SBIO.V balance_sheet (annual, 2024-12-31) — Other Equity Interest: 1771838.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1771838.00
SBIO.V income_statement (annual, 2024-12-31) — Other Gand A: 6101389.00
SBIO.V income_statement (quarterly, 2024-12-31) — Other Gand A: 2174762.00
SBIO.V income_statement (annual, 2024-12-31) — Other Income Expense: -842743.00
SBIO.V balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 260222.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 260222.00
SBIO.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: 289504.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 61301.00
SBIO.V income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 92824.00
SBIO.V income_statement (annual, 2024-12-31) — Other Special Charges: 842743.00
SBIO.V balance_sheet (annual, 2024-12-31) — Payables: 15358874.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Payables: 15358874.00
SBIO.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 15471154.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 15471154.00
SBIO.V income_statement (annual, 2024-12-31) — Pretax Income: -69269.00
SBIO.V income_statement (quarterly, 2024-12-31) — Pretax Income: 1203128.00
SBIO.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 5870.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 3625.00
SBIO.V balance_sheet (annual, 2024-12-31) — Properties: 0.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
SBIO.V cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -102861.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -27343.00
SBIO.V balance_sheet (annual, 2024-12-31) — Receivables: 14794353.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Receivables: 14794353.00
SBIO.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 18975496.00
SBIO.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 7014407.00
SBIO.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 882923.00
SBIO.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 193680.00
SBIO.V income_statement (annual, 2024-12-31) — Rent And Landing Fees: 672631.00
SBIO.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 187613.00
SBIO.V income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 672631.00
SBIO.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 187613.00
SBIO.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2825419.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -605877.00
SBIO.V cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -13560.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -12764.00
SBIO.V income_statement (annual, 2024-12-31) — Research And Development: 5761481.00
SBIO.V income_statement (quarterly, 2024-12-31) — Research And Development: 1783072.00
SBIO.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -15930297.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -15930297.00
SBIO.V income_statement (annual, 2024-12-31) — Salaries And Wages: 216037.00
SBIO.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 53129.00
SBIO.V income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 14927110.00
SBIO.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 4519573.00
SBIO.V income_statement (annual, 2024-12-31) — Selling General And Administration: 21917167.00
SBIO.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 6935077.00
SBIO.V balance_sheet (annual, 2024-12-31) — Share Issued: 50549485.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 50549485.00
SBIO.V income_statement (annual, 2024-12-31) — Special Income Charges: -842743.00
SBIO.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 220161.00
SBIO.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 53535.00
SBIO.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: -971647.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -971647.00
SBIO.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3710643.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -3710643.00
SBIO.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -176976.03
SBIO.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SBIO.V income_statement (annual, 2024-12-31) — Tax Provision: 41606.00
SBIO.V income_statement (quarterly, 2024-12-31) — Tax Provision: 8600.00
SBIO.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
SBIO.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.01
SBIO.V balance_sheet (annual, 2024-12-31) — Total Assets: 23110312.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 23110312.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Capitalization: -531647.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -531647.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Debt: 8568601.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 8568601.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -971647.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -971647.00
SBIO.V income_statement (annual, 2024-12-31) — Total Expenses: 47537067.00
SBIO.V income_statement (quarterly, 2024-12-31) — Total Expenses: 15926236.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 24081959.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 24081959.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4533688.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 4533688.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1704342.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1704342.00
SBIO.V income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 2065818.00
SBIO.V balance_sheet (annual, 2024-12-31) — Total Tax Payable: 46575.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 46575.00
SBIO.V income_statement (annual, 2024-12-31) — Total Unusual Items: -842743.00
SBIO.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -842743.00
SBIO.V balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 5500.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 5500.00
SBIO.V balance_sheet (annual, 2024-12-31) — Treasury Stock: 1809.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1809.00
SBIO.V balance_sheet (annual, 2024-12-31) — Working Capital: -3800993.00
SBIO.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -3800993.00
SBIO.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 7528957.00
SBIO.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 9087266.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11071037.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7353671.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1957581.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -173302.00
SBIO.V income_statement (quarterly, 2025-03-31) — Amortization: 44860.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 44860.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 44860.00
SBIO.V income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 44860.00
SBIO.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 50565835.00
SBIO.V income_statement (quarterly, 2025-03-31) — Basic EPS: -0.05
SBIO.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3300439.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3147750.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -7325.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1488727.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 13335109.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3820492.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3820492.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 3820492.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -444510.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -7325.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 971888.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -38249.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4251175.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -166342.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 7378526.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2922760.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 7378526.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 520053.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 13335109.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -3174028.00
SBIO.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3530847.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 90774.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 11876719.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 322452.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 6240991.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6563443.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3955.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3955.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 17787377.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Depreciation: 141449.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 186309.00
SBIO.V income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 186309.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 186309.00
SBIO.V income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 186309.00
SBIO.V income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 141449.00
SBIO.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 50565835.00
SBIO.V income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.05
SBIO.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2293202.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 62307.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Non Current: 29306.00
SBIO.V income_statement (quarterly, 2025-03-31) — EBIT: -1984876.00
SBIO.V income_statement (quarterly, 2025-03-31) — EBITDA: -1798567.00
SBIO.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 3820492.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -444510.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -83586.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 964563.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -83586.00
SBIO.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1714298.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2701461.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 7526973.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3147750.00
SBIO.V income_statement (quarterly, 2025-03-31) — Gross Profit: 5556419.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 58168.00
SBIO.V income_statement (quarterly, 2025-03-31) — Interest Expense: 295561.00
SBIO.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 295561.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Interest Payable: 90774.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3506963.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -7325.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 5050339.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1166275.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 440000.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1606275.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -269422.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 2860499.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 35542.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income: -2293202.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2293202.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2293202.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2293202.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2293202.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2293202.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2293202.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -7325.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -295561.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -443808.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -443808.00
SBIO.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -295561.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -702.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 1190169.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -5875489.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 29306.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 421969.00
SBIO.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1778292.00
SBIO.V income_statement (quarterly, 2025-03-31) — Normalized Income: -2277184.75
SBIO.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 971888.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 35542.00
SBIO.V income_statement (quarterly, 2025-03-31) — Operating Income: -1972538.00
SBIO.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 9087266.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 50582802.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 640249.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1190652.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1797948.00
SBIO.V income_statement (quarterly, 2025-03-31) — Other Gand A: 1462547.00
SBIO.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -12338.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 222687.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 65200.00
SBIO.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 7937.00
SBIO.V income_statement (quarterly, 2025-03-31) — Other Special Charges: 20275.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Payables: 11129205.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11219979.00
SBIO.V income_statement (quarterly, 2025-03-31) — Pretax Income: -2280437.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -7325.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Receivables: 7415978.00
SBIO.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3530847.00
SBIO.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 186309.00
SBIO.V income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 197066.00
SBIO.V income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 197066.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -269422.00
SBIO.V income_statement (quarterly, 2025-03-31) — Research And Development: 1939661.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -18223499.00
SBIO.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 54685.00
SBIO.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 3688689.00
SBIO.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5402987.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 50582802.00
SBIO.V income_statement (quarterly, 2025-03-31) — Special Income Charges: -20275.00
SBIO.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 55279.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -3174028.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -5875489.00
SBIO.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -4257.75
SBIO.V income_statement (quarterly, 2025-03-31) — Tax Provision: 12765.00
SBIO.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 16219624.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -2734028.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 8169718.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -3174028.00
SBIO.V income_statement (quarterly, 2025-03-31) — Total Expenses: 11059804.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 19393652.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4342905.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1606275.00
SBIO.V income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1972538.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 58168.00
SBIO.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -20275.00
SBIO.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -20275.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 0.00
SBIO.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -5910658.00
SBIO.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 8419607.00
SBIO.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 11157319.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10056195.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8823231.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2140628.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -151890.00
SBIO.V income_statement (quarterly, 2025-06-30) — Amortization: 44754.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 44754.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 44754.00
SBIO.V income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 44754.00
SBIO.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 50602702.00
SBIO.V income_statement (quarterly, 2025-06-30) — Basic EPS: -0.03
SBIO.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3820492.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 4404932.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -22830.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2685706.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 13363051.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2179928.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2179928.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 2179928.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1341838.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -22830.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2959572.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 234545.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -982346.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 214041.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1469560.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2003320.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1469560.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1640564.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 13363051.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -4435754.00
SBIO.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4339945.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 111303.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 11462373.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 710086.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Debt: 7724848.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 8434934.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 238500.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 238500.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 18911067.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Depreciation: 183047.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 227801.00
SBIO.V income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 227801.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 227801.00
SBIO.V income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 227801.00
SBIO.V income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 183047.00
SBIO.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 50602702.00
SBIO.V income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.03
SBIO.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1377658.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 62457.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Non Current: 31351.00
SBIO.V income_statement (quarterly, 2025-06-30) — EBIT: -1018434.00
SBIO.V income_statement (quarterly, 2025-06-30) — EBITDA: -790633.00
SBIO.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 2179928.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1341838.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -68728.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2982402.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -68728.00
SBIO.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2209138.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2679537.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 8975121.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4404932.00
SBIO.V income_statement (quarterly, 2025-06-30) — Gross Profit: 6817374.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 70135.00
SBIO.V income_statement (quarterly, 2025-06-30) — Interest Expense: 346838.00
SBIO.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 346838.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Interest Payable: 111303.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3727146.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -22830.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 6414152.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1975620.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 438052.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2413672.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -137876.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 5982972.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 14858.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income: -1377658.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1377658.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1377658.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1377658.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1377658.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1377658.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1377658.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -22830.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -346838.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 1344033.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1344033.00
SBIO.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -346838.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2195.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 2264304.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -7115291.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 31351.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 451420.00
SBIO.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1374432.00
SBIO.V income_statement (quarterly, 2025-06-30) — Normalized Income: -1838859.21
SBIO.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2959572.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 14858.00
SBIO.V income_statement (quarterly, 2025-06-30) — Operating Income: -1602233.00
SBIO.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 11157319.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 50619952.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 396757.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1310696.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1871080.00
SBIO.V income_statement (quarterly, 2025-06-30) — Other Gand A: 1914350.00
SBIO.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 583799.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 200763.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 77673.00
SBIO.V income_statement (quarterly, 2025-06-30) — Other Special Charges: -583799.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Payables: 10126330.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 10237633.00
SBIO.V income_statement (quarterly, 2025-06-30) — Pretax Income: -1365272.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -22830.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Receivables: 8885688.00
SBIO.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4339945.00
SBIO.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 227801.00
SBIO.V income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 198154.00
SBIO.V income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 198154.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -137876.00
SBIO.V income_statement (quarterly, 2025-06-30) — Research And Development: 1697295.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -19601157.00
SBIO.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 96634.00
SBIO.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 4285373.00
SBIO.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6494511.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 50619952.00
SBIO.V income_statement (quarterly, 2025-06-30) — Special Income Charges: 583799.00
SBIO.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 101074.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -4435754.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -7115291.00
SBIO.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 122597.79
SBIO.V income_statement (quarterly, 2025-06-30) — Tax Provision: 12386.00
SBIO.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 16888985.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -3997702.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 10848606.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -4435754.00
SBIO.V income_statement (quarterly, 2025-06-30) — Total Expenses: 12759552.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 21324739.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 5426612.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2413672.00
SBIO.V income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1602233.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 70135.00
SBIO.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: 583799.00
SBIO.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 583799.00
SBIO.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -7448694.00
SBIO.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 7828201.00
SBIO.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 8208049.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 13239352.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7721404.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2325688.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -73613.00
SBIO.V income_statement (quarterly, 2025-09-30) — Amortization: 43508.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 43508.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 43508.00
SBIO.V income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 43508.00
SBIO.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 50794808.00
SBIO.V income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
SBIO.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2179928.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 4404932.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -42664.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2554682.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 13501059.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1976770.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1976770.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 1976770.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1401963.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -42664.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1241469.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -19500.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3200707.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -82003.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1101827.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 4201031.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1101827.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -203158.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 13501059.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -7597756.00
SBIO.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3391058.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 85296.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 10240496.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 737022.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 6491879.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7228901.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 219000.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 219000.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20825549.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 1256274.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Depreciation: 185060.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 228568.00
SBIO.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 228568.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 228568.00
SBIO.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 228568.00
SBIO.V income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 185060.00
SBIO.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 50794808.00
SBIO.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
SBIO.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3347114.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 62607.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Non Current: 31285.00
SBIO.V income_statement (quarterly, 2025-09-30) — EBIT: -3018299.00
SBIO.V income_statement (quarterly, 2025-09-30) — EBITDA: -2789731.00
SBIO.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 1976770.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1401963.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -74018.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1198805.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -74018.00
SBIO.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1655356.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Goodwill: 2478774.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2678693.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 7795017.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4404932.00
SBIO.V income_statement (quarterly, 2025-09-30) — Gross Profit: 4816991.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 53000.00
SBIO.V income_statement (quarterly, 2025-09-30) — Interest Expense: 309447.00
SBIO.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 309447.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Interest Payable: 85296.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: -671147.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -42664.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 5230335.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1817660.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 434730.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2252390.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -207432.00
SBIO.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 4949839.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -5290.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income: -3347114.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3347114.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3347114.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3347114.00
SBIO.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3347114.00
SBIO.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3347114.00